PROFOUND MEDICAL CORP.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-42.6M | $-27.8M | $-28.3M |
| Depreciation & Amortization | — | — | — |
| Depreciation | $373.0K | $707.0K | $727.0K |
| Amortization | $187.0K | $229.0K | $202.0K |
| Stock-Based Compensation | $5.5M | $2.6M | $3.4M |
| Net Cash from Operating Activities | $-38.2M | $-23.5M | $-22.6M |
| Investing Activities | |||
| Capital Expenditures | $176.0K | — | — |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-242.0K | — | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $41.1M | $54.7M | $1.8M |
| Net Change in Cash | — | — | — |
| Free Cash Flow | $-38.4M | — | — |